8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  October 5, 2021

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following

    provisions \(see General Instruction A.2. below\):

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company       ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Section 5 – Corporate Governance and Management

The 2021 Annual Meeting (the "Annual Meeting") of Shareholders of STRATTEC SECURITY CORPORATION (the "Company")

        was held on October 5, 2021.  A total of 3,939,830 shares of the Company's Common Stock, par value $0.01 per share, were eligible and entitled to vote at the Annual Meeting and a total of 3,481,827 shares of the Company's Common Stock were
        represented at the Annual Meeting.  The matters voted on at the Annual Meeting were as follows:

The following individuals, each of whom was nominated for election to the Board of Directors, was elected by the shareholders at the Annual Meeting for a term of three years expiring at the 2023 Annual Meeting of shareholders.

The nomination of the above listed directors were made by the Board of Directors and no other nominations were made by any shareholder. Each of Mr. Stratton and Mr. Florsheim was completing a three year term as a member of the Board of Directors at the date of the Annual Meeting.

The terms of the following directors continued after the Annual Meeting: Frank J. Krejci (until the 2022 Annual Meeting of Shareholders); Michael J. Koss (until the 2023 Annual Meeting of Shareholders); and David R. Zimmer (until the 2023 Annual Meeting of Shareholders).

The shareholders voted at the Annual Meeting in favor of the proposed amendment to the Company's Amended and Restated Articles of Incorporation to increase the number of authorized shares of the Company's Common Stock from 12 million shares to 18 million shares.

The shareholders voted at the Annual Meeting in favor of the compensation of the Company's named executive officers as disclosed in the Proxy Statement for the Annual Meeting.

Section 9 - Financial Statements and Exhibits

104 – Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.